| Item Type | Name |
|
Concept
|
Acute Disease
|
|
Concept
|
Actins
|
|
Concept
|
Adrenal Cortex Hormones
|
|
Concept
|
Age Factors
|
|
Concept
|
Abdominal Muscles
|
|
Concept
|
Angiotensin II
|
|
Concept
|
Aorta, Thoracic
|
|
Concept
|
Aldosterone
|
|
Concept
|
Atropine Derivatives
|
|
Concept
|
Adenylyl Cyclases
|
|
Concept
|
Aerobiosis
|
|
Concept
|
Actinin
|
|
Concept
|
Adenoma
|
|
Concept
|
Cyclic AMP
|
|
Concept
|
Berberine
|
|
Concept
|
Biphenyl Compounds
|
|
Concept
|
Amino Acid Sequence
|
|
Concept
|
Mineralocorticoid Receptor Antagonists
|
|
Concept
|
Acetophenones
|
|
Concept
|
Boston
|
|
Concept
|
Anxiety
|
|
Concept
|
Apolipoproteins E
|
|
Concept
|
Androstadienes
|
|
Concept
|
Animals
|
|
Concept
|
Animals, Newborn
|
|
Concept
|
Angina Pectoris
|
|
Concept
|
Anti-Inflammatory Agents, Non-Steroidal
|
|
Concept
|
Aorta
|
|
Concept
|
Calmodulin
|
|
Concept
|
Aminoquinolines
|
|
Concept
|
Quaternary Ammonium Compounds
|
|
Concept
|
Antihypertensive Agents
|
|
Concept
|
Antioxidants
|
|
Concept
|
Analysis of Variance
|
|
Concept
|
Anions
|
|
Concept
|
Arginine
|
|
Concept
|
Anti-Inflammatory Agents
|
|
Concept
|
Histocompatibility Antigens Class II
|
|
Concept
|
B-Lymphocytes
|
|
Concept
|
Base Sequence
|
|
Concept
|
Cell Movement
|
|
Concept
|
Cell Nucleus
|
|
Concept
|
Cerebral Infarction
|
|
Concept
|
Diabetes Mellitus, Experimental
|
|
Concept
|
Aspirin
|
|
Concept
|
Atrial Fibrillation
|
|
Concept
|
Calcitriol
|
|
Concept
|
Binding Sites
|
|
Concept
|
Bleomycin
|
|
Concept
|
Calcinosis
|
|
Concept
|
Emergency Service, Hospital
|
|
Concept
|
Cardiology
|
|
Concept
|
Cattle
|
|
Concept
|
Cell Division
|
|
Concept
|
Cell Separation
|
|
Concept
|
Botulinum Toxins
|
|
Concept
|
Bronchoalveolar Lavage Fluid
|
|
Concept
|
Cholesterol, Dietary
|
|
Concept
|
Capillaries
|
|
Concept
|
Chemotaxis
|
|
Concept
|
Chicago
|
|
Concept
|
Cognition
|
|
Concept
|
Bradykinin
|
|
Concept
|
C-Reactive Protein
|
|
Concept
|
Cardiotonic Agents
|
|
Concept
|
Glutathione Transferase
|
|
Concept
|
Coronary Disease
|
|
Concept
|
Cholesterol
|
|
Concept
|
Circadian Rhythm
|
|
Concept
|
Coronary Artery Disease
|
|
Concept
|
Cytosol
|
|
Concept
|
Demography
|
|
Concept
|
Diabetes Mellitus, Type 1
|
|
Concept
|
Huntington Disease
|
|
Concept
|
Coronary Thrombosis
|
|
Concept
|
Hypersensitivity
|
|
Concept
|
Cytoplasm
|
|
Concept
|
Dexamethasone
|
|
Concept
|
Diabetic Angiopathies
|
|
Concept
|
Drug Synergism
|
|
Concept
|
Dendritic Cells
|
|
Concept
|
Dichlororibofuranosylbenzimidazole
|
|
Concept
|
Immunosuppressive Agents
|
|
Concept
|
Insulin
|
|
Concept
|
Interleukins
|
|
Concept
|
Endothelium, Vascular
|
|
Concept
|
Ergosterol
|
|
Concept
|
Cytochrome P-450 Enzyme System
|
|
Concept
|
Cytoskeleton
|
|
Concept
|
Cerebral Hemorrhage
|
|
Concept
|
Dogs
|
|
Concept
|
Cytotoxins
|
|
Concept
|
Electrophoresis, Polyacrylamide Gel
|
|
Concept
|
Germany
|
|
Concept
|
Heart Septum
|
|
Concept
|
Heart-Assist Devices
|
|
Concept
|
Enzyme Inhibitors
|
|
Concept
|
Epithelial Cells
|
|
Concept
|
Estradiol
|
|
Concept
|
Hyperaldosteronism
|
|
Concept
|
Immunologic Factors
|
|
Concept
|
Chronic Disease
|
|
Concept
|
Lysophospholipids
|
|
Concept
|
Coronary Vasospasm
|
|
Concept
|
Corpus Striatum
|
|
Concept
|
Cross-Sectional Studies
|
|
Concept
|
Disease Susceptibility
|
|
Concept
|
DNA
|
|
Concept
|
Double-Blind Method
|
|
Concept
|
Diterpenes
|
|
Concept
|
Metalloporphyrins
|
|
Concept
|
Indicators and Reagents
|
|
Concept
|
Indomethacin
|
|
Concept
|
Infant, Newborn
|
|
Concept
|
Introns
|
|
Concept
|
Electrocardiography
|
|
Concept
|
Mice, Inbred C3H
|
|
Concept
|
Microtubule-Associated Proteins
|
|
Concept
|
Molsidomine
|
|
Concept
|
Ergonovine
|
|
Concept
|
Myosin-Light-Chain Kinase
|
|
Concept
|
Atrial Natriuretic Factor
|
|
Concept
|
Gingiva
|
|
Concept
|
Genes, MHC Class II
|
|
Concept
|
Neovascularization, Pathologic
|
|
Concept
|
Nifedipine
|
|
Concept
|
KB Cells
|
|
Concept
|
Guanosine Triphosphate
|
|
Concept
|
Obesity
|
|
Concept
|
Office Visits
|
|
Concept
|
Cyclic GMP
|
|
Concept
|
Heart
|
|
Concept
|
Dose-Response Relationship, Drug
|
|
Concept
|
Hydrogen Peroxide
|
|
Concept
|
Hydroxyeicosatetraenoic Acids
|
|
Concept
|
Hyperlipidemias
|
|
Concept
|
Lipoproteins
|
|
Concept
|
Eosinophils
|
|
Concept
|
HLA-DR Antigens
|
|
Concept
|
Hydroxymethylglutaryl CoA Reductases
|
|
Concept
|
Flow Cytometry
|
|
Concept
|
Fluorescent Antibody Technique
|
|
Concept
|
Fluorobenzenes
|
|
Concept
|
Foam Cells
|
|
Concept
|
Inflammation
|
|
Concept
|
Interleukin-1
|
|
Concept
|
Glutathione
|
|
Concept
|
Lipoproteins, LDL
|
|
Concept
|
Macrophages
|
|
Concept
|
Ischemia
|
|
Concept
|
Isoflurane
|
|
Concept
|
Hostility
|
|
Concept
|
Mesenteric Arteries
|
|
Concept
|
Metalloendopeptidases
|
|
Concept
|
Metformin
|
|
Concept
|
Immunoglobulin E
|
|
Concept
|
Mice, Inbred Strains
|
|
Concept
|
Microfilament Proteins
|
|
Concept
|
Pilot Projects
|
|
Concept
|
Myocardial Infarction
|
|
Concept
|
Mice, Transgenic
|
|
Concept
|
Platelet-Derived Growth Factor
|
|
Concept
|
Potassium Chloride
|
|
Concept
|
Estrogens
|
|
Concept
|
Illinois
|
|
Concept
|
Immunohistochemistry
|
|
Concept
|
Organ Culture Techniques
|
|
Concept
|
Molecular Sequence Data
|
|
Concept
|
Muscle, Smooth, Vascular
|
|
Concept
|
Glycolysis
|
|
Concept
|
Oxadiazoles
|
|
Concept
|
Mesothelioma
|
|
Concept
|
Mevalonic Acid
|
|
Concept
|
Mice, Inbred BALB C
|
|
Concept
|
Mice, Inbred C57BL
|
|
Concept
|
Radiation Chimera
|
|
Concept
|
Receptors, Angiotensin
|
|
Concept
|
Myocardial Contraction
|
|
Concept
|
Cricetinae
|
|
Concept
|
Hemangioma, Cavernous
|
|
Concept
|
Hemangiosarcoma
|
|
Concept
|
Patient Admission
|
|
Concept
|
Patient Education as Topic
|
|
Concept
|
Nerve Growth Factors
|
|
Concept
|
Neural Tube Defects
|
|
Concept
|
Nitric Oxide
|
|
Concept
|
Naphthalenes
|
|
Concept
|
Laminin
|
|
Concept
|
Leg
|
|
Concept
|
Phosphodiesterase Inhibitors
|
|
Concept
|
Ovalbumin
|
|
Concept
|
Ligands
|
|
Concept
|
Lipopolysaccharides
|
|
Concept
|
Cholesterol, HDL
|
|
Concept
|
Lung Neoplasms
|
|
Concept
|
Lymphokines
|
|
Concept
|
Salicylates
|
|
Concept
|
Oxazepines
|
|
Concept
|
Patient Discharge
|
|
Concept
|
Patient Readmission
|
|
Concept
|
Penis
|
|
Concept
|
Sodium Salicylate
|
|
Concept
|
Morpholines
|
|
Concept
|
Muscle Proteins
|
|
Concept
|
Nitrites
|
|
Concept
|
Nitroprusside
|
|
Concept
|
Polyisoprenyl Phosphates
|
|
Concept
|
Oxygen
|
|
Concept
|
Fibrosis
|
|
Concept
|
Probability
|
|
Concept
|
Propylene Glycols
|
|
Concept
|
Preoperative Care
|
|
Concept
|
Protein Conformation
|
|
Concept
|
Forearm
|
|
Concept
|
Homocysteine
|
|
Concept
|
Immunoglobulin G
|
|
Concept
|
Immunoenzyme Techniques
|
|
Concept
|
Radiation Injuries
|
|
Concept
|
Recurrence
|
|
Concept
|
Regression Analysis
|
|
Concept
|
Heart Septal Defects, Ventricular
|
|
Concept
|
Rabbits
|
|
Concept
|
Receptors, Cell Surface
|
|
Concept
|
Referral and Consultation
|
|
Concept
|
Risk Factors
|
|
Concept
|
Urban Health
|
|
Concept
|
Uterine Hemorrhage
|
|
Concept
|
Receptors, LDL
|
|
Concept
|
Insulin Resistance
|
|
Concept
|
Interferon-gamma
|
|
Concept
|
Respiratory Hypersensitivity
|
|
Concept
|
ROC Curve
|
|
Concept
|
Cohort Studies
|
|
Concept
|
Receptors, Adrenergic, alpha
|
|
Concept
|
Sesquiterpenes
|
|
Concept
|
Cadherins
|
|
Concept
|
Interleukin-6
|
|
Concept
|
Japan
|
|
Concept
|
Risk
|
|
Concept
|
RNA Polymerase II
|
|
Concept
|
Sensitivity and Specificity
|
|
Concept
|
Swine
|
|
Concept
|
Hindlimb
|
|
Concept
|
Gonadal Steroid Hormones
|
|
Concept
|
Humans
|
|
Concept
|
Hypercholesterolemia
|
|
Concept
|
Body Mass Index
|
|
Concept
|
Incidence
|
|
Concept
|
Linear Models
|
|
Concept
|
Bone Marrow Transplantation
|
|
Concept
|
Endothelial Growth Factors
|
|
Concept
|
Ticlopidine
|
|
Concept
|
Superoxides
|
|
Concept
|
Statistics as Topic
|
|
Concept
|
Triiodothyronine
|
|
Concept
|
Tumor Necrosis Factor-alpha
|
|
Concept
|
Plasminogen Activator Inhibitor 1
|
|
Concept
|
Vasodilator Agents
|
|
Concept
|
Drug Design
|
|
Concept
|
Isosorbide Dinitrate
|
|
Concept
|
Ultraviolet Rays
|
|
Concept
|
Multicenter Studies as Topic
|
|
Concept
|
Cholesterol, LDL
|
|
Concept
|
Lung
|
|
Concept
|
Lovastatin
|
|
Concept
|
Thyroid Hormones
|
|
Concept
|
Randomized Controlled Trials as Topic
|
|
Concept
|
Macrophage Colony-Stimulating Factor
|
|
Concept
|
Risk Assessment
|
|
Concept
|
Reverse Transcriptase Polymerase Chain Reaction
|
|
Concept
|
Caspases
|
|
Concept
|
Respiratory Mucosa
|
|
Concept
|
Peptide Elongation Factor 1
|
|
Concept
|
Guanine Nucleotide Exchange Factors
|
|
Concept
|
RGS Proteins
|
|
Concept
|
rho GTP-Binding Proteins
|
|
Concept
|
rhoB GTP-Binding Protein
|
|
Concept
|
Tyrosine
|
|
Concept
|
rac1 GTP-Binding Protein
|
|
Concept
|
Raloxifene Hydrochloride
|
|
Concept
|
Mitogen-Activated Protein Kinases
|
|
Concept
|
Vasoconstrictor Agents
|
|
Concept
|
Veratrine
|
|
Concept
|
Transforming Growth Factor beta
|
|
Concept
|
Guanosine 5'-O-(3-Thiotriphosphate)
|
|
Concept
|
Keratinocytes
|
|
Concept
|
Cell Adhesion Molecules
|
|
Concept
|
Global Health
|
|
Concept
|
Mice, Inbred ICR
|
|
Concept
|
Mitochondria
|
|
Concept
|
Mitochondria, Muscle
|
|
Concept
|
Reperfusion Injury
|
|
Concept
|
CD4-Positive T-Lymphocytes
|
|
Concept
|
Radionuclide Ventriculography
|
|
Concept
|
Chi-Square Distribution
|
|
Concept
|
Interleukin-8
|
|
Concept
|
Cytochalasin D
|
|
Concept
|
Eicosanoids
|
|
Concept
|
Rats, Sprague-Dawley
|
|
Concept
|
Rats, Wistar
|
|
Concept
|
Muscle Contraction
|
|
Concept
|
Myocardium
|
|
Concept
|
Case-Control Studies
|
|
Concept
|
Sp1 Transcription Factor
|
|
Concept
|
T-Cell Antigen Receptor Specificity
|
|
Concept
|
In Situ Hybridization
|
|
Concept
|
Protein Structure, Tertiary
|
|
Concept
|
Fractals
|
|
Concept
|
Melanoma
|
|
Concept
|
Mental Health
|
|
Concept
|
Genes, Reporter
|
|
Concept
|
Motor Activity
|
|
Concept
|
Treatment Outcome
|
|
Concept
|
Myosins
|
|
Concept
|
Angiopoietin-2
|
|
Concept
|
Receptor, Bradykinin B1
|
|
Concept
|
Neurites
|
|
Concept
|
Hypertrophy, Left Ventricular
|
|
Concept
|
Gelatinases
|
|
Concept
|
Laser-Doppler Flowmetry
|
|
Concept
|
Annexin A5
|
|
Concept
|
Gene Deletion
|
|
Concept
|
Mice, Knockout
|
|
Concept
|
Receptors, Bradykinin
|
|
Concept
|
DNA, Complementary
|
|
Concept
|
Receptors, AMPA
|
|
Concept
|
Cell Proliferation
|
|
Concept
|
Inflammation Mediators
|
|
Concept
|
GTP-Binding Protein alpha Subunits, Gs
|
|
Concept
|
omega-N-Methylarginine
|
|
Concept
|
Muscle, Skeletal
|
|
Concept
|
ras Proteins
|
|
Concept
|
Interferon-Stimulated Gene Factor 3
|
|
Concept
|
Apoptosis Regulatory Proteins
|
|
Concept
|
Th2 Cells
|
|
Concept
|
Simvastatin
|
|
Concept
|
Infarction, Middle Cerebral Artery
|
|
Concept
|
GTP-Binding Protein alpha Subunits, Gi-Go
|
|
Concept
|
Bone Morphogenetic Protein Receptors, Type II
|
|
Concept
|
Caspase 3
|
|
Concept
|
Estrogen Receptor Modulators
|
|
Concept
|
Natriuretic Peptide, Brain
|
|
Concept
|
Metabolic Syndrome
|
|
Concept
|
Cross-Over Studies
|
|
Concept
|
Neuroprotective Agents
|
|
Concept
|
Ankle Brachial Index
|
|
Concept
|
P-Selectin
|
|
Concept
|
Fluorescent Antibody Technique, Indirect
|
|
Concept
|
GTP Phosphohydrolases
|
|
Concept
|
Intracranial Embolism
|
|
Concept
|
Matrix Metalloproteinase 2
|
|
Concept
|
Selective Estrogen Receptor Modulators
|
|
Concept
|
Rifabutin
|
|
Concept
|
Cyclic GMP-Dependent Protein Kinases
|
|
Concept
|
Myofibroblasts
|
|
Concept
|
Genetic Pleiotropy
|
|
Concept
|
Oxidants, Photochemical
|
|
Concept
|
Pertussis Toxin
|
|
Concept
|
Vascular Endothelial Growth Factor Receptor-2
|
|
Concept
|
Myosin-Light-Chain Phosphatase
|
|
Concept
|
Receptor, Bradykinin B2
|
|
Concept
|
Receptor, Angiotensin, Type 2
|
|
Concept
|
PPAR gamma
|
|
Concept
|
Green Fluorescent Proteins
|
|
Concept
|
Vascular Endothelial Growth Factors
|
|
Concept
|
Microarray Analysis
|
|
Concept
|
Sterol Regulatory Element Binding Protein 2
|
|
Concept
|
Lactams, Macrocyclic
|
|
Concept
|
Angiotensin II Type 1 Receptor Blockers
|
|
Concept
|
Endothelin-1
|
|
Concept
|
Area Under Curve
|
|
Concept
|
COS Cells
|
|
Concept
|
Amino Acid Substitution
|
|
Concept
|
Organizational Case Studies
|
|
Concept
|
3' Untranslated Regions
|
|
Concept
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors
|
|
Concept
|
Somites
|
|
Concept
|
Adoptive Transfer
|
|
Concept
|
Matrix Metalloproteinase 3
|
|
Concept
|
ras GTPase-Activating Proteins
|
|
Concept
|
rhoA GTP-Binding Protein
|
|
Concept
|
rac GTP-Binding Proteins
|
|
Concept
|
Embryo Loss
|
|
Concept
|
Platelet Endothelial Cell Adhesion Molecule-1
|
|
Concept
|
Cytoprotection
|
|
Concept
|
Cationic Amino Acid Transporter 1
|
|
Concept
|
Sirolimus
|
|
Concept
|
Goblet Cells
|
|
Concept
|
Myocytes, Cardiac
|
|
Concept
|
I-kappa B Proteins
|
|
Concept
|
Hemangioma, Cavernous, Central Nervous System
|
|
Concept
|
Cyclin-Dependent Kinase Inhibitor p21
|
|
Concept
|
Oncogene Protein v-akt
|
|
Concept
|
Postoperative Complications
|
|
Concept
|
Precipitin Tests
|
|
Concept
|
Promoter Regions, Genetic
|
|
Concept
|
Mice
|
|
Concept
|
Early Growth Response Protein 1
|
|
Concept
|
Receptors, Notch
|
|
Concept
|
Receptors, Glucocorticoid
|
|
Concept
|
Pyrroles
|
|
Concept
|
Rats, Inbred Strains
|
|
Concept
|
Severity of Illness Index
|
|
Concept
|
Acute Coronary Syndrome
|
|
Concept
|
Renin
|
|
Concept
|
RNA, Messenger
|
|
Concept
|
Glycogen Synthase Kinase 3
|
|
Concept
|
Spironolactone
|
|
Concept
|
Farnesyl-Diphosphate Farnesyltransferase
|
|
Concept
|
Sulfonamides
|
|
Concept
|
Taiwan
|
|
Concept
|
Angiogenesis Inducing Agents
|
|
Concept
|
Propensity Score
|
|
Concept
|
Interferon Regulatory Factors
|
|
Concept
|
GATA4 Transcription Factor
|
|
Concept
|
Rats
|
|
Concept
|
Nitric Oxide Synthase Type II
|
|
Concept
|
Period Circadian Proteins
|
|
Concept
|
TOR Serine-Threonine Kinases
|
|
Concept
|
Human Umbilical Vein Endothelial Cells
|
|
Concept
|
Sex Factors
|
|
Concept
|
Osteopontin
|
|
Concept
|
Vitamin D
|
|
Concept
|
Adaptor Proteins, Signal Transducing
|
|
Concept
|
Dyslipidemias
|
|
Concept
|
Chemokine CXCL10
|
|
Concept
|
Immunoblotting
|
|
Concept
|
Blotting, Western
|
|
Concept
|
Autoimmunity
|
|
Concept
|
Toll-Like Receptor 4
|
|
Concept
|
Multivariate Analysis
|
|
Concept
|
Logistic Models
|
|
Concept
|
Survival Analysis
|
|
Concept
|
Cyclins
|
|
Concept
|
Angiotensin II Type 2 Receptor Blockers
|
|
Concept
|
Phosphatidylinositol 3-Kinase
|
|
Concept
|
Blotting, Northern
|
|
Concept
|
Meta-Analysis as Topic
|
|
Concept
|
Reproducibility of Results
|
|
Concept
|
Molecular Structure
|
|
Concept
|
Survival Rate
|
|
Concept
|
Odds Ratio
|
|
Concept
|
Polymerase Chain Reaction
|
|
Concept
|
ATP-Binding Cassette Transporters
|
|
Concept
|
Intercellular Adhesion Molecule-1
|
|
Concept
|
Cellular Senescence
|
|
Concept
|
Coronary Angiography
|
|
Concept
|
Cyclin-Dependent Kinases
|
|
Concept
|
Protein Prenylation
|
|
Concept
|
GTP-Binding Proteins
|
|
Concept
|
NADPH Oxidases
|
|
Concept
|
NG-Nitroarginine Methyl Ester
|
|
Concept
|
Integrases
|
|
Concept
|
Matrix Metalloproteinases, Membrane-Associated
|
|
Concept
|
Myeloid Differentiation Factor 88
|
|
Concept
|
Thioredoxin Reductase 1
|
|
Concept
|
Mitogen-Activated Protein Kinase 1
|
|
Concept
|
Troponin T
|
|
Concept
|
Intracranial Hemorrhages
|
|
Concept
|
Interleukin-17
|
|
Concept
|
cdc42 GTP-Binding Protein
|
|
Concept
|
Xenograft Model Antitumor Assays
|
|
Concept
|
Gene Knockdown Techniques
|
|
Concept
|
Homeodomain Proteins
|
|
Concept
|
Interleukin-13
|
|
Concept
|
HSP90 Heat-Shock Proteins
|
|
Concept
|
Germinal Center
|
|
Concept
|
Nitric Oxide Synthase
|
|
Concept
|
Vascular Cell Adhesion Molecule-1
|
|
Concept
|
Phosphatidylinositol 3-Kinases
|
|
Concept
|
Blood Vessel Prosthesis Implantation
|
|
Concept
|
Carotid Artery Injuries
|
|
Concept
|
Monomeric GTP-Binding Proteins
|
|
Concept
|
GTPase-Activating Proteins
|
|
Concept
|
MAP Kinase Signaling System
|
|
Concept
|
Receptor, TIE-2
|
|
Concept
|
JNK Mitogen-Activated Protein Kinases
|
|
Concept
|
Extracellular Signal-Regulated MAP Kinases
|
|
Concept
|
S-Nitrosoglutathione
|
|
Concept
|
gamma Catenin
|
|
Concept
|
I-kappa B Kinase
|
|
Concept
|
Keratin-14
|
|
Concept
|
Haploinsufficiency
|
|
Concept
|
Angiotensin Receptor Antagonists
|
|
Concept
|
RNA, Small Interfering
|
|
Concept
|
Vascular Endothelial Growth Factor A
|
|
Concept
|
Endothelial Cells
|
|
Concept
|
LIM-Homeodomain Proteins
|
|
Concept
|
GTP-Binding Protein alpha Subunits, Gq-G11
|
|
Concept
|
MAP Kinase Kinase Kinase 5
|
|
Concept
|
Lipid Metabolism
|
|
Concept
|
Cyclin-Dependent Kinase Inhibitor p27
|
|
Concept
|
Receptor, Notch1
|
|
Concept
|
Nitric Oxide Synthase Type III
|
|
Concept
|
Kaplan-Meier Estimate
|
|
Concept
|
rho-Associated Kinases
|
|
Concept
|
Idiopathic Pulmonary Fibrosis
|
|
Concept
|
Nuclear Receptor Coactivator 3
|
|
Concept
|
Allergens
|
|
Concept
|
Anticholesteremic Agents
|
|
Concept
|
Hypolipidemic Agents
|
|
Concept
|
Brain Neoplasms
|
|
Concept
|
Calcium
|
|
Concept
|
Calcium Channel Blockers
|
|
Concept
|
Cardiovascular Agents
|
|
Concept
|
Clinical Trials as Topic
|
|
Concept
|
Community Health Workers
|
|
Concept
|
Desmosomes
|
|
Concept
|
Diabetes Mellitus
|
|
Concept
|
Disease Models, Animal
|
|
Concept
|
Drugs, Chinese Herbal
|
|
Concept
|
Follow-Up Studies
|
|
Concept
|
Genetic Testing
|
|
Concept
|
Glucose
|
|
Concept
|
Heart Rate
|
|
Concept
|
Hemorrhage
|
|
Concept
|
Hyperglycemia
|
|
Concept
|
Immunity, Innate
|
|
Concept
|
Ionophores
|
|
Concept
|
Longitudinal Studies
|
|
Concept
|
Magnetic Resonance Imaging
|
|
Concept
|
Mice, Mutant Strains
|
|
Concept
|
Microscopy, Fluorescence
|
|
Concept
|
Models, Biological
|
|
Concept
|
Models, Neurological
|
|
Concept
|
Monocytes
|
|
Concept
|
Platelet Aggregation Inhibitors
|
|
Concept
|
Predictive Value of Tests
|
|
Concept
|
Proadifen
|
|
Concept
|
Prospective Studies
|
|
Concept
|
Retrospective Studies
|
|
Concept
|
Sphingosine
|
|
Concept
|
T-Lymphocytes
|
|
Concept
|
Terpenes
|
|
Concept
|
Neuroimmunomodulation
|
|
Concept
|
Interleukin-5
|
|
Concept
|
Cytokines
|
|
Concept
|
Pravastatin
|
|
Concept
|
Cyclic AMP-Dependent Protein Kinases
|
|
Concept
|
DNA Primers
|
|
Concept
|
Receptors, Neurotransmitter
|
|
Concept
|
Porins
|
|
Concept
|
Coculture Techniques
|
|
Concept
|
E-Selectin
|
|
Concept
|
1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine
|
|
Concept
|
Nitroarginine
|
|
Concept
|
Chemokines, CXC
|
|
Concept
|
Losartan
|
|
Concept
|
Genetic Predisposition to Disease
|
|
Concept
|
Nitric Oxide Donors
|
|
Concept
|
Proto-Oncogene Proteins c-sis
|
|
Concept
|
Polymorphism, Single Nucleotide
|
|
Concept
|
Adherens Junctions
|
|
Concept
|
Mitochondrial Membrane Transport Proteins
|
|
Concept
|
Vesicular Transport Proteins
|
|
Concept
|
Adaptor Proteins, Vesicular Transport
|
|
Concept
|
MicroRNAs
|
|
Concept
|
ADP Ribose Transferases
|
|
Concept
|
Vascular Endothelial Growth Factor Receptor-1
|
|
Concept
|
Protein Kinase Inhibitors
|
|
Concept
|
p38 Mitogen-Activated Protein Kinases
|
|
Concept
|
Receptors, Lysosphingolipid
|
|
Concept
|
Proto-Oncogene Proteins c-akt
|
|
Concept
|
Smad Proteins
|
|
Concept
|
HLA-DR alpha-Chains
|
|
Academic Article
|
Rho-kinase mediates hypoxia-induced downregulation of endothelial nitric oxide synthase.
|
|
Academic Article
|
Nongenomic mechanisms of endothelial nitric oxide synthase activation by the selective estrogen receptor modulator raloxifene.
|
|
Academic Article
|
Inhibition of Rho-kinase leads to rapid activation of phosphatidylinositol 3-kinase/protein kinase Akt and cardiovascular protection.
|
|
Academic Article
|
Short-term statin therapy improves cardiac function and symptoms in patients with idiopathic dilated cardiomyopathy.
|
|
Academic Article
|
Increased Rho kinase activity in a Taiwanese population with metabolic syndrome.
|
|
Academic Article
|
Risk of coronary artery disease associated with polymorphism of the cytochrome P450 epoxygenase CYP2J2.
|
|
Academic Article
|
Identification of ROCK1 as an upstream activator of the JIP-3 to JNK signaling axis in response to UVB damage.
|
|
Academic Article
|
A method for measuring Rho kinase activity in tissues and cells.
|
|
Academic Article
|
Inhibition of Rho kinase (ROCK) leads to increased cerebral blood flow and stroke protection.
|
|
Academic Article
|
Squalene synthase inhibitor lapaquistat acetate: could anything be better than statins?
|
|
Academic Article
|
Increased leukocyte Rho-associated coiled-coil containing protein kinase activity predicts the presence and severity of coronary vasospastic angina.
|
|
Academic Article
|
Statins inhibit Rho kinase activity in patients with atherosclerosis.
|
|
Academic Article
|
Statins and cardiovascular diseases: from cholesterol lowering to pleiotropy.
|
|
Academic Article
|
Role of Rho kinase isoforms in murine allergic airway responses.
|
|
Academic Article
|
Measurement of Rho-associated kinase (ROCK) activity in humans: validity of leukocyte p-MBS/t-MBS in comparison with vascular response to fasudil.
|
|
Academic Article
|
Rho-associated coiled-coil-containing kinase 2 deficiency in bone marrow-derived cells leads to increased cholesterol efflux and decreased atherosclerosis.
|
|
Academic Article
|
Roles of rho-associated kinase and oxidative stress in the pathogenesis of aortic stiffness.
|
|
Academic Article
|
Rho-associated kinase activity, endothelial function, and cardiovascular risk factors.
|
|
Academic Article
|
Induction of angiogenesis by heat shock protein 90 mediated by protein kinase Akt and endothelial nitric oxide synthase.
|
|
Academic Article
|
Effects of statins on 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibition beyond low-density lipoprotein cholesterol.
|
|
Academic Article
|
Decreased vascular lesion formation in mice with inducible endothelial-specific expression of protein kinase Akt.
|
|
Academic Article
|
A novel pleiotropic effect of statins: prevention of cardiac hypertrophy by cholesterol-independent mechanisms.
|
|
Academic Article
|
Molecular basis of cell membrane estrogen receptor interaction with phosphatidylinositol 3-kinase in endothelial cells.
|
|
Academic Article
|
Rho kinase inhibition improves endothelial function in human subjects with coronary artery disease.
|
|
Academic Article
|
A mouse model of diet-induced obesity and insulin resistance.
|
|
Academic Article
|
Pleiotropic effects of statins.
|
|
Academic Article
|
Elevated rho-kinase activity as a marker indicating atherosclerosis and inflammation burden in polyvascular disease patients with concomitant coronary and peripheral arterial disease.
|
|
Academic Article
|
FHL2/SLIM3 decreases cardiomyocyte survival by inhibitory interaction with sphingosine kinase-1.
|
|
Academic Article
|
Translational therapeutics of dipyridamole.
|
|
Academic Article
|
Comparison of effects of rosuvastatin (10 mg) versus atorvastatin (40 mg) on rho kinase activity in caucasian men with a previous atherosclerotic event.
|
|
Academic Article
|
Statins exert the pleiotropic effects through small GTP-binding protein dissociation stimulator upregulation with a resultant Rac1 degradation.
|
|
Academic Article
|
Linking endothelial dysfunction with endothelial cell activation.
|
|
Academic Article
|
Acute cardiovascular protective effects of corticosteroids are mediated by non-transcriptional activation of endothelial nitric oxide synthase.
|
|
Academic Article
|
Phosphatidylinositol 3-kinase/protein kinase Akt negatively regulates plasminogen activator inhibitor type 1 expression in vascular endothelial cells.
|
|
Academic Article
|
VEGF increases retinal vascular ICAM-1 expression in vivo.
|
|
Academic Article
|
Safety and efficacy of statins in Asians.
|
|
Academic Article
|
Abrogation of airway hyperresponsiveness but not inflammation by rho kinase insufficiency.
|
|
Academic Article
|
Rho-kinase inhibition acutely augments blood flow in focal cerebral ischemia via endothelial mechanisms.
|
|
Academic Article
|
1alpha,25-dihydroxyvitamin D3 induces vascular smooth muscle cell migration via activation of phosphatidylinositol 3-kinase.
|
|
Academic Article
|
Rapid nontranscriptional activation of endothelial nitric oxide synthase mediates increased cerebral blood flow and stroke protection by corticosteroids.
|
|
Academic Article
|
Statins: potent vascular anti-inflammatory agents.
|
|
Academic Article
|
Anti-inflammatory properties of cytochrome P450 epoxygenase-derived eicosanoids.
|
|
Academic Article
|
Cross-coupling between the oestrogen receptor and phosphoinositide 3-kinase.
|
|
Academic Article
|
ROCKs as therapeutic targets in cardiovascular diseases.
|
|
Academic Article
|
NF-?B and innate immunity in ischemic stroke.
|
|
Academic Article
|
Nontranscriptional actions of the glucocorticoid receptor.
|
|
Academic Article
|
Activation of the phosphatidylinositol 3-kinase/protein kinase Akt pathway mediates nitric oxide-induced endothelial cell migration and angiogenesis.
|
|
Academic Article
|
Pleiotropic effects of statin therapy: molecular mechanisms and clinical results.
|
|
Academic Article
|
Inhibition of Rho-kinase attenuates endothelial-leukocyte interaction during ischemia-reperfusion injury.
|
|
Academic Article
|
Striatal neurons expressing full-length mutant huntingtin exhibit decreased N-cadherin and altered neuritogenesis.
|
|
Academic Article
|
Inhibition of endothelial vascular cell adhesion molecule-1 expression by nitric oxide involves the induction and nuclear translocation of IkappaBalpha.
|
|
Academic Article
|
ROCK1 mediates leukocyte recruitment and neointima formation following vascular injury.
|
|
Academic Article
|
Activation of Galpha s mediates induction of tissue-type plasminogen activator gene transcription by epoxyeicosatrienoic acids.
|
|
Academic Article
|
Linking Notch signaling to ischemic stroke.
|
|
Academic Article
|
[New findings on the action of HMG-CoA-reductase inhibitors].
|
|
Academic Article
|
Simvastatin decreases IL-6 and IL-8 production in epithelial cells.
|
|
Academic Article
|
Statin therapy: having the good without the bad.
|
|
Academic Article
|
Statins and myocardial hypertrophy.
|
|
Academic Article
|
Salicylates and vascular smooth muscle cell proliferation: molecular mechanisms for cell cycle arrest.
|
|
Academic Article
|
Absence of TRAM restricts Toll-like receptor 4 signaling in vascular endothelial cells to the MyD88 pathway.
|
|
Academic Article
|
Inhibition of 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase blocks hypoxia-mediated down-regulation of endothelial nitric oxide synthase.
|
|
Academic Article
|
Post-transcriptional regulation of endothelial nitric oxide synthase mRNA stability by Rho GTPase.
|
|
Academic Article
|
FHL2 prevents cardiac hypertrophy in mice with cardiac-specific deletion of ROCK2.
|
|
Academic Article
|
Rapid nongenomic actions of thyroid hormone.
|
|
Academic Article
|
Rho kinase (ROCK) inhibitors.
|
|
Academic Article
|
Inhibition of vascular smooth muscle cell migration by cytochrome p450 epoxygenase-derived eicosanoids.
|
|
Academic Article
|
Interaction of oestrogen receptor with the regulatory subunit of phosphatidylinositol-3-OH kinase.
|
|
Academic Article
|
Exogenous nitric oxide inhibits Rho-associated kinase activity in patients with angina pectoris: a randomized controlled trial.
|
|
Academic Article
|
ROCK insufficiency attenuates ozone-induced airway hyperresponsiveness in mice.
|
|
Academic Article
|
Distribution of sphingosine kinase activity and mRNA in rodent brain.
|
|
Academic Article
|
Increased leukocyte ROCK activity in patients after acute ischemic stroke.
|
|
Academic Article
|
Drug Insight: statins and stroke.
|
|
Academic Article
|
11,12-epoxyeicosatrienoic acid (11,12-EET): structural determinants for inhibition of TNF-alpha-induced VCAM-1 expression.
|
|
Academic Article
|
Role of statin pleiotropism in acute coronary syndromes and stroke.
|
|
Academic Article
|
Interventional Transcatheter Closure Ameliorates the Leukocyte Rho Kinase Activities among Patients with Patent Ductus Arteriosus.
|
|
Academic Article
|
Elevated Angiopoietin-2 Level in Patients With Continuous-Flow Left Ventricular Assist Devices Leads to Altered Angiogenesis and Is Associated With Higher Nonsurgical Bleeding.
|
|
Academic Article
|
RhoA Kinase Inhibition With Fasudil Versus Simvastatin in Murine Models of Cerebral Cavernous Malformations.
|
|
Academic Article
|
Role of ROCK2 in CD4+ cells in allergic airways responses in mice.
|
|
Academic Article
|
Targeting Rho in cardiovascular disease.
|
|
Academic Article
|
Lipid management with statins. The lower the better?
|
|
Academic Article
|
Tumor necrosis factor-alpha downregulates endothelial nitric oxide synthase mRNA stability via translation elongation factor 1-alpha 1.
|
|
Academic Article
|
Simvastatin reverses cardiac hypertrophy caused by disruption of the bradykinin 2 receptor.
|
|
Academic Article
|
Beyond lipid lowering: the role of statins in vascular protection.
|
|
Academic Article
|
Statin therapy for cardiac hypertrophy and heart failure.
|
|
Academic Article
|
Acute reduction of myocardial infarct size by a hydroxymethyl glutaryl coenzyme A reductase inhibitor is mediated by endothelial nitric oxide synthase.
|
|
Academic Article
|
Vascular protection by estrogen in ischemia-reperfusion injury requires endothelial nitric oxide synthase.
|
|
Academic Article
|
Impaired Cognitive Performance in Endothelial Nitric Oxide Synthase Knockout Mice After Ischemic Stroke: A Pilot Study.
|
|
Academic Article
|
Simvastatin preserves cardiac function in genetically determined cardiomyopathy.
|
|
Academic Article
|
The Rho Kinase Isoforms ROCK1 and ROCK2 Each Contribute to the Development of Experimental Pulmonary Fibrosis.
|
|
Academic Article
|
Rho Kinase Inhibition Blunts Lesion Development and Hemorrhage in Murine Models of Aggressive Pdcd10/Ccm3 Disease.
|
|
Academic Article
|
Targeting Rho-associated coiled-coil forming protein kinase (ROCK) in cardiovascular fibrosis and stiffening.
|
|
Academic Article
|
Long-term statin use and psychological well-being.
|
|
Academic Article
|
SALAD-BAAR: A numerical risk score for hospital admission or emergency department presentation in ambulatory patients with cardiovascular disease.
|
|
Academic Article
|
Emerging views of statin pleiotropy and cholesterol lowering.
|
|
Academic Article
|
Tie2-Cre-Induced Inactivation of Non-Nuclear Estrogen Receptor-a Signaling Abrogates Estrogen Protection Against Vascular Injury.
|
|
Concept
|
Neuroprotection
|
|
Concept
|
Fingolimod Hydrochloride
|
|
Concept
|
Rosuvastatin Calcium
|
|
Concept
|
Ezetimibe
|
|
Concept
|
Liver X Receptors
|
|
Concept
|
Receptor, Notch3
|
|
Concept
|
NF-KappaB Inhibitor alpha
|
|
Concept
|
Glycogen Synthase Kinase 3 beta
|
|
Concept
|
Proof of Concept Study
|
|
Concept
|
KRIT1 Protein
|
|
Concept
|
Zonula Occludens-1 Protein
|
|
Concept
|
Tertiary Care Centers
|
|
Concept
|
Percutaneous Coronary Intervention
|
|
Concept
|
Tight Junction Proteins
|
|
Concept
|
ATP Binding Cassette Transporter 1
|
|
Concept
|
Social Determinants of Health
|
|
Concept
|
Cytochrome P-450 Enzyme Inhibitors
|
|
Concept
|
In Vitro Techniques
|
|
Concept
|
Vascular Remodeling
|
|
Grant
|
Cellular Determinants of Adipocyte Phenotype and Function
|
|
Grant
|
Endothelial Akt in Vascular Injury
|
|
Grant
|
ROCK and Obesity
|
|
Grant
|
Lipoproteins Effect on G Protein Function
|
|
Grant
|
Activation of eNOS by Steroid Hormones
|
|
Grant
|
Role of PI3-Kinase in Estrogen-induced eNOS Activation
|